Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.02.17.638570

Extraction of biological terms using large language models enhances the usability of metadata in the BioSample database

Abstract

BioSample is a comprehensive repository of experimental sample metadata, playing a crucial role in providing a comprehensive archive and enabling experiment searches regardless of type. However, the difficulty in comprehensively defining the rules for describing metadata and limited user awareness of best practices for metadata have resulted in substantial variability depending on the submitter. This inconsistency poses significant challenges to the findability and reusability of the data. Given the vast scale of BioSample, which hosts over 40 million records, manual curation is impractical. Rule-based automatic ontology mapping methods have been proposed to address this issue, but their effectiveness is limited by the heterogeneity of BioSample metadata. Recently, large language models (LLMs) have gained attention in natural language processing and have been expected as promising tools for automating metadata curation. In this study, we evaluated the performance of LLMs in extracting cell line names from BioSample descriptions using a gold-standard dataset derived from ChIP-Atlas, a secondary database of epigenomics experiment data, which manually curates samples. Our results demonstrated that LLM-assisted methods outperformed traditional approaches, achieving higher accuracy and coverage. We further extended this approach to extraction of information about experimentally manipulated genes from metadata where manual curation had not yet been applied in ChIP-Atlas. This also yielded successful results for the usage of the database, which facilitates more precise filtering of data and prevents misinterpretation caused by inclusion of unintended data. These findings underscore the potential of LLMs to improve the findability and reusability of experimental data in general, significantly reducing user workload and enabling more effective scientific data management.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ikeda, S., Zou, Z., Bono, H., Moriya, Y., Kawashima, S., Katayama, T., Oki, S., Ohta, T.. 2025-02-22. Extraction of biological terms using large language models enhances the usability of metadata in the BioSample database. https://doi.org/10.1101/2025.02.17.638570

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗